Release Date: 01/05/12 19:24 Summary: App3B Director Incentive Option Issue Price Sensitive: No Download Document 474.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%